Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study

L Staerk, T A Gerds, G .Y. H. Lip, B. Ozenne, A. N. Bonde, M. Lamberts, E. L. Fosbøl, C. Torp-Pedersen, G. H. Gislason, J. B. Olesen